1.800GBp0.00%Mkt Cap: 7.87M GBpP/E: —Last update: 2026-06-01
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States. It offers KidneyIntelX, a diagnostic platform that employs …
Industry Peers
Health Information Services30.40BUSDP/E 34.2
11.78BUSDP/E 78.9
9.57BUSD—
7.71BUSDP/E 34.5
7.53BSEKP/E 33.6
5.29BTRYP/E 28.3
4.72BUSD—
4.18BUSDP/E 32.5
Indicators:|
Key Statistics
Company
Market Cap7.87M GBp
Enterprise Value7.47M GBp
Revenue (TTM)3.30M GBp
Gross Profit1.20M GBp
Net Income (TTM)-20.40M GBp
Revenue/Share0.0090 GBp
Last Price1.800 GBp
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees46
CountryGB
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.20
PEG—
EV/EBITDA—
EV/Revenue2.26
P/S2.38
P/B-8.12
EPS (TTM)-0.03
EPS (Forward)-0.09
52W Range
1.6001% of range15.50
52W High15.50 GBp
52W Low1.600 GBp
Profitability
Gross Margin40.00%
Oper. Margin-437.50%
EBITDA Margin0.00%
Profit Margin-680.00%
ROE291.43%
ROA-334.43%
Growth
Revenue Growth2.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-17.90M GBp
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt-400.00K GBp
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-1.19
Current Ratio1.57
Quick Ratio1.39
Book Value/Sh-0.0022 GBp
Cash/Share0.0140 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.437.02M
Float363.95M
Insiders26.69%
Institutions57.69%
Technical
SMA 501.943 (-7.4%)
SMA 2005.258 (-65.8%)
Beta1.82
S&P 52W Chg27.94%
Avg Vol (30d)851.42K
Avg Vol (10d)265.89K
Technical Indicators
RSI (14)13.5
MACD-0.0713
MACD Signal-0.0990
MACD Hist.+0.0276
BB Upper1.800 GBp
BB Middle1.800 GBp
BB Lower1.800 GBp
BB Width0.00%
ATR (14)0.3185 GBp
Vol Ratio (20d)1.92x